# Editorial: Immuno-metabolic approaches for the treatment of hepatobiliary and pancreatic tumors

**Authors:** Yuanxia Han, Luyu Yang, Jianwei Xu, Hengrui Liu, Ran Wei

PMC · DOI: 10.3389/fimmu.2026.1810064 · Frontiers in Immunology · 2026-02-23

## Full-text entities

- **Genes:** CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, GDF15 (growth differentiation factor 15) [NCBI Gene 9518] {aka GDF-15, HG, MIC-1, MIC1, NAG-1, PDF}
- **Diseases:** HCC (MESH:D006528), Hepatobiliary and Pancreatic Tumors (MESH:D010190), fibrosis (MESH:D005355), HL (MESH:C538324), PDAC (MESH:D021441), cancer (MESH:D009369)
- **Chemicals:** reactive oxygen species (MESH:D017382), HAIC (-), tyrosine (MESH:D014443)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968278/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968278/full.md

---
Source: https://tomesphere.com/paper/PMC12968278